Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IN RE: K-V Pharmaceutical Company Securities Litigation
Case Number:
4:11-cv-01816
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
June 06, 2014
K-V Investors Can't Save Suit Over Pregnancy Drug
A Missouri federal judge on Friday dismissed K-V Pharmaceutical Co. investors' consolidated securities fraud class action accusing the company of lying about prospects for pregnancy drug Makena, artificially inflating the stock price that later plummeted, and refused their proposals to amend it.
-
October 20, 2011
Investor Says K-V Lied About Pregnancy Drug's Prospects
A K-V Pharmaceutical Co. shareholder filed a putative class action in Missouri on Wednesday claiming the drugmaker lied to investors about prospects for pregnancy drug Makena, artificially inflating the stock price that later plummeted when demand for the drug fizzled.